Scanlan Sean F.
SEC CIK 1856371 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| TMCI | TREACE MEDICAL CONCEPTS, INC. | SVP, Marketing | 679.9K | — | $5.40M | 40 | 2021-11-10 | 2026-08-09 |
Most active insiders at TMCI, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Treace John T. | CEO, Dir, 10% | $1.45M | — |
| 2 | Guglielmino Gaetano | Chief Commercial Off | — | — |
| 3 | Elder Scot Michael | Chief Legl, Comp Off, CorpSec | — | — |
| 4 | Hanna Betsy | Dir | — | — |
| 5 | Scanlan Sean F. | Chief Innovation Off | — | — |
| 6 | Jain Deepti | Dir | — | — |
| 7 | Hair Mark | CFO | — | — |
| 8 | Berry Lance A | Dir | — | — |
| 9 | Kiernan Jane E | Dir | — | — |
| 10 | HAMILTON LAWRENCE W | Dir | — | — |
Transactions 40
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-12 18:00 | 2026-08-09 | TMCI | TREACE MEDICAL CONCEPTS, INC. | Scanlan Sean F. | Chief Innovation Off | F - Tax | $0.00 | -9,814 | 679.9K | -1% | $0 | |
| M | 2026-03-11 | 2026-03-08+ | TMCI | TREACE MEDICAL CONCEPTS, INC. | Scanlan Sean F. | Chief Innovation Off | F - Tax | $0.00 | -1,797 | 706.1K | -0.3% | $0 |
| D | 2026-02-11 | 2026-02-10 | TMCI | TREACE MEDICAL CONCEPTS, INC. | Scanlan Sean F. | Chief Innovation Off | M - OptEx | $1.05 | +16.9K | 706.5K | +2% | +$17.7K |
| D | 2026-01-23 | 2026-01-22 | TMCI | TREACE MEDICAL CONCEPTS, INC. | Scanlan Sean F. | Chief Innovation Off | A - Grant | $0.00 | +262.5K | 689.6K | +61% | $0 |
| D | 2026-01-23 | 2026-01-21 | TMCI | TREACE MEDICAL CONCEPTS, INC. | Scanlan Sean F. | Chief Innovation Off | M - OptEx | $0.72 | +53.5K | 427.1K | +14% | +$38.5K |
| 2025-10-28 | 2025-10-24 | TMCI | TREACE MEDICAL CONCEPTS, INC. | Scanlan Sean F. | Chief Innovation Off | F - Tax | $0.00 | -208 | 373.6K | -0.1% | $0 | |
| 2025-08-12 | 2025-08-09 | TMCI | TREACE MEDICAL CONCEPTS, INC. | Scanlan Sean F. | Chief Innovation Off | F - Tax | $0.00 | -9,814 | 373.8K | -3% | $0 | |
| D | 2025-07-22 | 2025-07-18 | TMCI | TREACE MEDICAL CONCEPTS, INC. | Scanlan Sean F. | Chief Innovation Off | M - OptEx | $0.72 | +33.4K | 383.6K | +10% | +$24.1K |
| DT | 2025-03-19 | 2025-03-17 | TMCI | TREACE MEDICAL CONCEPTS, INC. | Scanlan Sean F. | Chief Innovation Off | S - Sale+OE | $7.97 | -50.0K | 364.1K | -12% | -$398.5K |
| DT | 2025-03-19 | 2025-03-17 | TMCI | TREACE MEDICAL CONCEPTS, INC. | Scanlan Sean F. | Chief Innovation Off | M - OptEx | $1.05 | +50.0K | 414.1K | +14% | +$52.5K |
| M | 2025-03-11 | 2025-03-08+ | TMCI | TREACE MEDICAL CONCEPTS, INC. | Scanlan Sean F. | Chief Innovation Off | F - Tax | $0.00 | -1,797 | 365.5K | -0.5% | $0 |
| 2025-01-24 | 2025-01-22 | TMCI | TREACE MEDICAL CONCEPTS, INC. | Scanlan Sean F. | Chief Innovation Off | A - Grant | $0.00 | +140.6K | 365.9K | +62% | $0 | |
| 2025-01-14 | 2025-01-10 | TMCI | TREACE MEDICAL CONCEPTS, INC. | Scanlan Sean F. | Chief Innovation Off | F - Tax | $0.00 | -4,821 | 225.3K | -2% | $0 | |
| D | 2024-09-16 | 2024-09-12 | TMCI | TREACE MEDICAL CONCEPTS, INC. | Scanlan Sean F. | Chief Innovation Off | M - OptEx | $0.1 | +33.8K | 250.1K | +16% | +$3,375 |
| 2024-08-09 | 2024-08-09 | TMCI | TREACE MEDICAL CONCEPTS, INC. | Scanlan Sean F. | Chief Innovation Off | A - Grant | $0.00 | +120.9K | 216.3K | +127% | $0 | |
| M | 2024-03-12 | 2024-03-08+ | TMCI | TREACE MEDICAL CONCEPTS, INC. | Scanlan Sean F. | Chief Innovation Off | F - Tax | $0.00 | -1,785 | 95.4K | -2% | $0 |
| D | 2024-01-12 | 2024-01-10 | TMCI | TREACE MEDICAL CONCEPTS, INC. | Scanlan Sean F. | Chief Innovation Off | A - Grant | $0.00 | +65.0K | 97.2K | +202% | $0 |
| 2023-11-03 | 2023-11-02 | TMCI | TREACE MEDICAL CONCEPTS, INC. | Scanlan Sean F. | Chief Innovation Off | F - Tax | $0.00 | -211 | 32.2K | -0.7% | $0 | |
| D | 2023-05-18 | 2023-05-16 | TMCI | TREACE MEDICAL CONCEPTS, INC. | Scanlan Sean F. | Chief Innovation Off | M - OptEx | $0.1 | +25.0K | 57.4K | +77% | +$2,500 |
| D | 2023-05-18 | 2023-05-16 | TMCI | TREACE MEDICAL CONCEPTS, INC. | Scanlan Sean F. | Chief Innovation Off | S - Sale+OE | $25.44 | -25.0K | 32.4K | -44% | -$636.0K |
| D | 2023-03-10 | 2023-03-09 | TMCI | TREACE MEDICAL CONCEPTS, INC. | Scanlan Sean F. | Chief Innovation Off | S - Sale | $24.41 | -505 | 9,470 | -5% | -$12.3K |
| D | 2023-03-10 | 2023-03-10 | TMCI | TREACE MEDICAL CONCEPTS, INC. | Scanlan Sean F. | Chief Innovation Off | A - Grant | $0.00 | +22.9K | 32.4K | +242% | $0 |
| D | 2023-02-17 | 2023-02-15 | TMCI | TREACE MEDICAL CONCEPTS, INC. | Scanlan Sean F. | Chief Innovation Off | M - OptEx | $0.1 | +25.0K | 35.0K | +251% | +$2,500 |
| D | 2023-02-17 | 2023-02-15 | TMCI | TREACE MEDICAL CONCEPTS, INC. | Scanlan Sean F. | Chief Innovation Off | S - Sale+OE | $21.69 | -25.0K | 9,975 | -71% | -$542.2K |
| D | 2023-01-13 | 2023-01-12 | TMCI | TREACE MEDICAL CONCEPTS, INC. | Scanlan Sean F. | Chief Innovation Off | M - OptEx | $0.1 | +25.0K | 35.0K | +251% | +$2,500 |
| D | 2023-01-13 | 2023-01-12 | TMCI | TREACE MEDICAL CONCEPTS, INC. | Scanlan Sean F. | Chief Innovation Off | S - Sale+OE | $25.57 | -25.0K | 9,975 | -71% | -$639.2K |
| D | 2022-11-16 | 2022-11-14 | TMCI | TREACE MEDICAL CONCEPTS, INC. | Scanlan Sean F. | SVP, Marketing | S - Sale+OE | $24.27 | -25.0K | 9,975 | -71% | -$606.8K |
| D | 2022-11-16 | 2022-11-14 | TMCI | TREACE MEDICAL CONCEPTS, INC. | Scanlan Sean F. | SVP, Marketing | M - OptEx | $0.1 | +25.0K | 35.0K | +251% | +$2,500 |
| D | 2022-10-26 | 2022-10-24 | TMCI | TREACE MEDICAL CONCEPTS, INC. | Scanlan Sean F. | SVP, Marketing | A - Grant | $0.00 | +3,400 | 9,975 | +52% | $0 |
| D | 2022-03-10 | 2022-03-08 | TMCI | TREACE MEDICAL CONCEPTS, INC. | Scanlan Sean F. | SVP, Marketing | A - Grant | $0.00 | +6,575 | 6,575 | New | $0 |
| D | 2022-03-04 | 2022-03-02 | TMCI | TREACE MEDICAL CONCEPTS, INC. | Scanlan Sean F. | SVP, Marketing | M - OptEx | $1.05 | +25.0K | 25.0K | New | +$26.2K |
| D | 2022-03-04 | 2022-03-02 | TMCI | TREACE MEDICAL CONCEPTS, INC. | Scanlan Sean F. | SVP, Marketing | S - Sale+OE | $20.82 | -25.0K | 0 | -100% | -$520.5K |
| DM | 2022-02-10 | 2022-02-08+ | TMCI | TREACE MEDICAL CONCEPTS, INC. | Scanlan Sean F. | SVP, Marketing | S - Sale+OE | $20.04 | -25.0K | 0 | -100% | -$501.0K |
| DM | 2022-02-10 | 2022-02-08+ | TMCI | TREACE MEDICAL CONCEPTS, INC. | Scanlan Sean F. | SVP, Marketing | M - OptEx | $1.05 | +25.0K | 3,873 | New | +$26.2K |
| DM | 2022-01-12 | 2022-01-10+ | TMCI | TREACE MEDICAL CONCEPTS, INC. | Scanlan Sean F. | SVP, Marketing | M - OptEx | $1.50 | +47.7K | 2,424 | New | +$71.6K |
| DM | 2022-01-12 | 2022-01-10+ | TMCI | TREACE MEDICAL CONCEPTS, INC. | Scanlan Sean F. | SVP, Marketing | S - Sale+OE | $20.15 | -47.7K | 0 | -100% | -$961.3K |
| DM | 2022-01-05 | 2022-01-03+ | TMCI | TREACE MEDICAL CONCEPTS, INC. | Scanlan Sean F. | SVP, Marketing | M - OptEx | $1.57 | +2,300 | 800 | New | +$3,611 |
| DM | 2022-01-05 | 2022-01-03+ | TMCI | TREACE MEDICAL CONCEPTS, INC. | Scanlan Sean F. | SVP, Marketing | S - Sale+OE | $20.02 | -2,300 | 0 | -100% | -$46.0K |
| DM | 2021-11-12 | 2021-11-10 | TMCI | TREACE MEDICAL CONCEPTS, INC. | Scanlan Sean F. | SVP, Marketing | S - Sale+OE | $21.54 | -25.0K | 440 | -98% | -$538.5K |
| D | 2021-11-12 | 2021-11-10 | TMCI | TREACE MEDICAL CONCEPTS, INC. | Scanlan Sean F. | SVP, Marketing | M - OptEx | $1.57 | +25.0K | 25.0K | New | +$39.2K |
Purchase Sale Sale after option exercise All abbreviations